通过为社区药剂师开发和验证算法,优化2型糖尿病和慢性病患者的处方
Jennifer Morris1, Marisa Battistella2,3,4, Karthik Tennankore5,6
1Faculty of Health, College of Pharmacy, Dalhousie University, Halifax, NS, Canada.
Canadian journal of kidney health and disease
|January 21, 2025
概括
社区药剂师现在可以使用验证的算法识别和管理2型糖尿病 (T2D) 和慢性病 (CKD). 这些工具旨在改善初级保健机构对脏保护药物的处方.
科学领域:
- 药理学和病学 药理学和病学
- 初级保健创新初级保健的创新
- 医疗保健服务研究 医疗服务研究
背景情况:
- 糖尿病是导致功能衰竭的主要原因,在慢性病 (CKD) 初级保健中发现和管理2型糖尿病 (T2D) 的差距很大.
- 社区药剂师为那些无法获得传统脏护理途径的患者提供了至关重要的资源.
- 开发了算法,使药剂师能够在CKD患者中识别T2D并开处方保护药物.
研究的目的:
- 为社区药剂师开发和验证算法,以确认T2D和CKD.
- 为了使药剂师能够为30-60毫升/分钟/1.73米2的eGFR患者开处方指南导向疗法.
- 通过优化药剂师能力,增强T2D和CKD患者的初级保健.
主要方法:
- 使用林恩的三步方法开发了算法,结合了脏学,内分泌学,家庭医学,护理和药学方面的证据和专家共识.
- 内容和面部有效性由18名社区药剂师在三个轮评估,使用问卷和采访.
- 量化指标包括项目级内容有效性指数 (I-CVI),规模级内容有效性指数 (S-CVI/Ave) 和面值有效性陈述的百分比一致性.
主要成果:
- 算法实现了高内容有效性,I-CVI在0.83到1之间 (P < .05) 和S-CVI/Ave在0.97.
- 面部有效性也很高,药剂师在关键陈述上达成83%-100%的共识.
- 这项研究涉及18名社区药剂师,平均有18年的经验.
结论:
- 经过验证的算法为社区药剂师提供了一个新的模型,用于在初级保健中识别和管理T2D和CKD.
- 开发的算法展示了强大的内容和面部有效性.
- 未来的实施和评估是必要的,以确认这种新的护理模式的有效性和安全性.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
01:11Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
01:17Factors Affecting Renal Clearance: Renal Impairment
51
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
51
01:12Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K